InMed Pharmaceuticals INM
NASDAQ INM
$1.35 -0.01 (-0.74%)
At close: Oct 1, 2026 · 4:00 PM EDT

InMed Pharmaceuticals (INM) Other Non-Current Liabilities (2020 - 2021)

Updated

InMed Pharmaceuticals' Other Non-Current Liabilities came in at $1.76 million for fiscal Q3 2021 (quarter ended Mar 31, 2021), unchanged from the prior quarter.

Analysis

InMed Pharmaceuticals (INM) Other Non-Current Liabilities (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Linde 218.80 Bn 201.92 Bn 4.43 Bn
2 Corning 132.43 Bn 125.56 Bn 1.63 Bn
3 Sherwin Williams 78.49 Bn 77.53 Bn 3.34 Bn
4 Air Products & Chemicals 61.97 Bn 59.87 Bn 1.04 Bn
5 Corteva 51.82 Bn 40.62 Bn 3.66 Bn
6 LyondellBasell Industries 37.12 Bn 26.74 Bn 2.04 Bn
7 Nutrien 33.86 Bn 30.73 Bn 3.25 Bn
8 Qnity Electronics 26.31 Bn 23.73 Bn 666.00 Mn
9 Ati 25.78 Bn 23.93 Bn 309.80 Mn
10 InMed Pharmaceuticals 5.66 Mn 3.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 1.76 Mn
Dec 31, 2020 1.76 Mn
API Access

InMed Pharmaceuticals Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=INM&period=max&api_key=YOUR_API_KEY